A. Frisch, “Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy”, J Med Cases, vol. 17, no. 1, pp. 28–31, Jan. 2026, doi: 10.14740/jmc5211.